WebFeb 3, 2024 · PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) pat... ATX 3 233 0,2% DAX 15 776 0,3% Dow 34 030 1,1% EStoxx50 4 375 0,3% Nasdaq 13 109 2,0% Öl 85,8 -0,5% Euro 1,1070 0,2% CHF 0,9828 0,0% Gold 2 039 -0,1% WebFeb 22, 2024 · Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBD Nicole Drago 2024-03-02T07:05:24-08:00 2024-03-02 Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn’s Disease Patients
Prometheus Launches New Indication for PredictrPK® IFX, A …
WebSep 9, 2024 · PredictrPK IFX Induction (#3500) and Maintenance (#3400) are precision-dosing tests that require patient-speci fic inputs. All information requested, in their … WebMar 2, 2024 · PredictrPK IFX addresses the unmet need to quickly assess a patient's PK profile to facilitate individualized precision-guided dosing of IFX. The test offers guidance … help epmhoa.com
Prometheus Launches New Indication for PredictrPK® IFX, A …
WebMar 2, 2024 · SAN DIEGO, March 2, 2024 /PRNewswire/ -- Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, announced the launch of an induction-phase indication for PredictrPK IFX, a ... WebFeb 17, 2024 · PredictrPK IFX is the first in a family of PredictrPK tests, and trials are underway to expand use of the test to earlier in patient management, said Dr. Thierry Dervieux, PhD, chief scientific officer at Prometheus, in a news release. WebMar 2, 2024 · About PredictrPK ® IFX PredictrPK IFX is validated for adult and pediatric IBD patients receiving IFX or IFX biosimilars. Combining serology markers, patient- and disease-specific variables, current dosing, and a proprietary machine-learning algorithm, PredictrPK IFX provides individualized, actionable insights to support optimized dosing. help enough other people get what they want